Introduction Leishmaniasis is a vector borne protozoan infestation and manifested as cutaneous, visceral and muco-cutaneous lesions in human. Visceral form is the most virulent type and the annual incidence was 0.2-0.4 million cases around the world. 1 But, in Sri Lanka, Cutaneous Leishmaniasis (CL) is a newly established disease and is emerging as a threat to public health. 2 In Sri Lanka the condition is still not fully investigated nor well studied. Method The aim of this descriptive cross-sectional study was to determine the prevalence of CL in the patients coming to the dermatology unit and clinic of the District General Hospital, Matara, Sri Lanka. The study was conducted from August 2016 to March 2017. Results There were 129 participants subjected to Leishmanin Skin Test accompanied with direct interviews and physical examination. The most of participants were males (52.8%), 68.4% of them unskilled. The highest prevalent type was Non scaly nodule (45.0%). Most common site of lesion was arm (47.1%). Majority had a single lesion (76.7%). Co-existing skin manifestations of hypopigmentation (36.9%) was the commonest. In (63.6%), co-existing skin lesions involved only less than 2% of body surface area. The hypopigmentation was significantly associated with Age, Sex and work outdoor while photodermatitis was significantlyassociated with age and photosensitivity. Eczematisation was significantly associated with diabetes mellitus and hyperlipidaemia. Conclusions Cutaneous Leishmaniasis is more prevalent among 31-41-year age group and males. Majority are primary, single, early presentationandnon-scaly nodule. The limbs are the commonest affected site.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.